The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats
Authors:
- Dominika StygarDSDominika Stygar
- Tomasz SawczynTSTomasz Sawczyn
- Bronisława Skrzep-PoloczekBSBronisława Skrzep-Poloczek
- Aleksander J. OwczarekAOAleksander J. Owczarek
- Natalia MatysiakNMNatalia Matysiak
- Marek MichalskiMMMarek Michalski
- Łukasz MielańczykŁMŁukasz Mielańczyk
- Piotr ChoręzaPCPiotr Choręza
- Bogdan DoleżychBDBogdan Doleżych
Open Access
- 24 August 2017
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (3) , 748-759
Abstract
Background Despite excellent results of bariatric surgery in the treatment of type 2 diabetes and weight loss in human subjects, some patients do not obtain desired results. One of the reasons for this is that not all patients follow caloric intake recommendations. Aim The aim of this study was to investigate the effect of duodenojejunal omega switch (DJOS) surgery on body weight, glucose tolerance, and incretins in rats. Methods DJOS and SHAM surgery were performed on rats maintained for 8 weeks on high-fat diet (HF) and control diet (CD), respectively. After surgery, four groups were kept on the same diet as before the surgery, and four groups had a changed diet (CD vs. HF and HF vs. CD) for the next 8 weeks. Glucose tolerance, insulin tolerance, glucose-stimulated insulin, glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide (GIP) secretion, food intake, and body weight were measured. Results A change of diet after surgery resulted in reduced glucose tolerance. Plasma insulin levels were lowered between DJOS and SHAM surgeries for the HF/HF and CD/HF groups. DJOS surgery did not reduce body weight in the studied groups, irrespective of diet. In the HF/HF group, ΔGLP-1 was lower for DJOS surgery in comparison with other groups. Differences of weight changes were observed for groups HF/HF and HF/CD. After DJOS surgery, ΔGIP was lower in the CD/HF group compared with HF/HF. Conclusions Our results show that applications of different types of diets, before and after surgery, is a sensitive method for studies of mechanism of glucose intolerance after DJOS surgery.Keywords
This publication has 35 references indexed in Scilit:
- Mechanisms of fat‐induced gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide secretion from K cellsJournal of Diabetes Investigation, 2016
- Systematic ileal transposition in Zucker rats shows advantage for long segment distal transpositionSurgery, 2014
- Gastric bypass reduces fat intake and preferenceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitisLiver International, 2011
- A high-fat diet inhibits the progression of diabetes mellitus in type 2 diabetic ratsNutrition Research, 2010
- Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for ObesityObesity Surgery, 2010
- Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetesInternational Journal of Obesity, 2009
- Ileal Interposition Improves Glucose Tolerance in Low Dose Streptozotocin-treated Diabetic and Euglycemic RatsObesity Surgery, 2008
- Ileal Transposition Controls Diabetes as Well as Modified Duodenal Jejunal Bypass With Better Lipid Lowering in a Nonobese Rat Model of Type II Diabetes by Increasing GLP-1Annals of Surgery, 2008
- Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group studyThe Lancet, 2002